Cardiac transplantation, effective therapy for end-stage heart failure, is frequently complicated by allograft rejection, the mechanisms of which remain incompletely understood. Nitric oxide (NO), a vasodilator which is cytotoxic and negatively inotropic, can be produced in large amounts by an inducible NO synthase (iNOS) in response to cytokines. To investigate whether iNOS is induced during cardiac allograft rejection, hearts from Lewis or Wistar-Furth rats were transplanted into Lewis recipients. At day 5, allogeneic grafts manifested reduced contractility and histologic evidence of rejection (inflammatory infiltrate, edema, necrosis of myocytes). The mRNA for iNOS and iNOS protein were detected in ventricular homogenates and in isolated cardiac myocytes from rejecting allogeneic grafts but not in tissue and myocytes from syngeneic control grafts. Immunocytochemistry showed increased iNOS staining in infiltrating macrophages and in microvascular endothelial cells and cardiac muscle fibers and also in isolated purified cardiac myocytes from the rejecting allografts. Using a myocardial cytosolic iNOS preparation, nitrite formation from L-arginine and [3H] citrulline formation from [3H] L-arginine were increased significantly in the rejecting allogeneic grafts (P < 0.01). Myocardial cyclic GMP was also increased significantly (P < 0.05). The data indicate myocardial iNOS mRNA, protein and enzyme activity are induced in infiltrating macrophages and cardiac myocytes of the rejecting allogeneic grafts. Synthesis of NO by iNOS may contribute to myocyte necrosis and ventricular failure during cardiac allograft rejection. (J. Clin. Invest. 1994. 94:714-721.)
Introduction
Cardiac transplantation is recognized as the most effective therapy for end-stage heart failure with one and five year survival rates currently exceeding 80 and 65%, respectively (1) . Despite this success, allograft rejection continues to be a major obstacle to long-term survival. This results in diminished ventricular contractile performance and necrosis of cardiac myocytes which are manifested clinically by congestive failure, low cardiac out-put, hypotension, and reduced pressor responses to catecholamines. Allograft rejection also results in the development of accelerated atherosclerosis in the coronary arteries of the transplanted heart which is manifested clinically by myocardial infarction and sudden death (2) . There is a large body of knowledge concerning the immunological reactions which are involved in cardiac allograft rejection (3, 4) . However, the cellular and biochemical mechanisms responsible for the development of contractile failure and necrosis of cardiac myocytes during cardiac allograft rejection are poorly understood.
The oxidation of L-arginine to biologically active nitric oxide(NO)' is important in a wide variety of physiological and pathological processes (5) (6) (7) . A family of enzymes, the nitric oxide synthases (NOS), catalyze the oxidation of one of the terminal guanidino nitrogens of L-arginine to yield NO and citrulline. In effector cells NO interacts with soluble guanylyl cyclases to increase formation of cyclic GMP and to initiate biological responses. Constitutive nitric oxide synthases require calcium and calmodulin as cofactors. Constitutive NOS in endothelial cells generates low levels of NO in response to hormones or sheer stress which increases levels of cyclic GMP in platelets and in endothelial and vascular smooth muscle cells promoting vasodilation, inhibition of platelet adhesion, and aggregation and inhibition of leukocyte adhesion. Constitutive NOS in brain and neurons of the nonadrenergic, noncholinergic nervous system generates NO which functions as a neurotransmitter (5) (6) (7) . Inducible nitric oxide synthases (iNOS) are not present under basal conditions, but are expressed in response to cytokines or bacterial endotoxin in macrophages, endothelial cells, vascular smooth muscle cells, and cardiac myocytes (5) (6) (7) . Inducible NO synthases do not require calcium and calmodulin as cofactors and generate substantially larger amounts of NO for longer periods of time. NO produced by iNOS in activated macrophages is cytotoxic and involved in their antimicrobial actions. NO produced by iNOS in vascular smooth muscle cells and cardiac myocytes in response to bacterial endotoxin has been implicated in the pathogenesis of hypotension in association with infection by gram negative bacteria (5) .
In cardiac tissue NO production may occur via both constitutive and inducible NO synthases. The basal production of NO by constitutive NOS in coronary arterial and microvascular endothelial cells is important in the maintenance of coronary vascular tone (8, 9) . NO production by endocardial and endothelial cells may also influence myocardial contraction (8, (10) (11) (12) . NO produced by constitutive NOS in cardiac myocytes does not appear from current evidence to have a major influence on basal contractility of cardiac myocytes but it can modulate heart rate responses to muscarinic cholinergic agonists and inhibit the inotropic response to 13-adrenergic agonists (11, 12) . Inducible NOS has been expressed in normal ventricular tissue IFN-y) and bacterial endotoxin (5, 6, (13) (14) (15) . The continuous and large production of NO by iNOS in cardiac myocytes has been shown to influence heart rate and to modulate myocardial contractile responses (14, 16) .
Current evidence indicates that during allograft rejection there is a major release of cytokines by activated T lymphocytes and macrophages which participate in the immune reaction to foreign HLA and other antigens present in endothelial and other cells of the transplanted organ (3, 4, 17) . Cytokines, particularly those released by the Th-l subset of lymphocytes, have been shown to promote the expression of iNOS in several systems (18, 19 (25 ,ug per lane) was separated on 8% SDS-polyacrylamide gel electrophoresis and transferred to nitrocellulose membranes. After overnight blocking in Tris-buffered saline with 3% nonfat dried milk and 2% BSA and subsequent washing, the blots were immunoblotted with the rabbit anti-macrophage iNOS antiserum (1:1,000) as described. An anti-rabbit Ig conjugated to horseradish peroxidase (Amersham), was used as secondary antibody. Blots were detected with the enhanced chemiluminescence method (Amersham).
Determinations of NO synthase activity. The excised hearts were rinsed and perfused with ice-cold saline to remove blood completely. Ventricular tissue was homogenized in ice-cold buffer containing 50 mM Tris-HCl, pH 7.4, 0.05 mM EDTA, 0.5 mM DL-dithiotreitol, 10 gg/ml of antipain, leupeptin, and trypsin inhibitor and 0.1 mg/ml of phenylmethylsulfonyl fluoride. Homogenates were centrifuged at 100,000 g for 60 min at 4°C. Supernatants were adjusted to a protein content of 2 mg/ml using BCA protein assay (Pierce, Rockford, IL) and bovine serum albumin as standard, and were used for the enzyme activity assay immediately. NO (26) .
Determination of cyclic GMP. Freshly isolated myocytes were extracted in ice-cold 0.1 N HCl for 30 min and then centrifuged at 10,000 g for 20 min at 4°C. Supernatants were neutralized with 1.0 N NaOH and protein content was measured as described above. Supernatants were kept at -70°C and measured in a single assay using a cGMP radioimmunoassay kit (Amersham). The intra-assay coefficient of variation was 8% (n = 5). (Fig. 4 , lanes I and 2; n = 5). Isolated cardiac myocytes from both sets of grafts were purified > 90% using a Percoll density gradient followed by adhesion of the myocytes to laminin coated dishes. Purification was assessed by staining cells of the myocyte fraction from the allografts with hematoxylin and eosin (Fig. 5 b) . Abundant iNOS was detected in isolated and purified myocytes from rejecting allografts (Fig. 4 , lane 4, n = 5), but not in purified myocytes from syngeneic controls (Fig. 4, lane 3) . Cells from the rejecting allografts that sedimented on the Percoll gradient between 1.061 and 1.050 g/ml were found to be a mixture of predominantly macrophages and some lymphocytes together with damaged cardiac myocytes (Fig. 5 a) . The iNOS protein was revealed in the mononuclear cell fraction from the rejecting allografts (Fig. 4, lane 6) , while no band was visible in the same density gradient fraction from the syngeneic controls (Fig. 4, lane 5) . The iNOS protein was not detected in Western blots of neonatal rat cardiac myocytes that had been maintained in tissue culture until there were no contaminating inflammatory cells (Fig. 4, lane 7) ; however, the iNOS protein was detected in cultured neonatal cardiac myocytes that had been treated for 24 h with cytokines (IL-1/3 5 ng/ml, IFN-y 9 ng/ml, and TNFa
The time course of the pathological changes in the WistarFurth:Lewis allogeneic allografts is depicted in Fig. 1 . At day 1 the histology of the allogeneic allografts was normal as were the syngeneic grafts (Fig. 1 a) . At day 3 there was a slight infiltrate of lymphocytes and macrophages (Fig. 1 b) . At day 5 there was a marked inflammatory infiltrate of lymphocytes and macrophages with tissue edema and necrosis of myocytes (Fig. 1 c) . At day 6 necrosis of cardiac myocytes was more extensive (Fig. 1 d) . With this transplantation model cessation of the heart beat due to rejection usually occurs at 7 to 9 d.
Northern analysis revealed abundant iNOS mRNA signal at (lanes 7 and 8) was induced by 5 ng/ml of IL-l1,, 9 ng/ml of IFN-y, and 25 ng/ml of TNF-a as positive control. U, untreated; C, cytokine treated. 25 ng/ml) known to induce the enzyme in these cells (Fig. 4 , lane 8). Western blots from syngeneic and allogenic grafts on days 1 and 3 revealed no detectable iNOS band.
Myocardial cytosolic iNOS preparations were made from 100,000 g supernatants of ventricular homogenates. The activity of iNOS was assessed by incubating the crude enzyme preparations with L-arginine and cofactors specific for the inducible enzyme and measurement of nitrite with the Greiss reagent. Nitrite formation from L-arginine was increased significantly in the rejecting allografts in comparison to the low basal levels observed in the syngeneic controls at day 5 (Fig. 6 , n = 6, P < .01). Only minimal levels of nitrite were detected at days 1 and 3 from allogeneic grafts (n = 2). Conversion of [3H]Larginine to [3H]L-citrulline by the cytosolic enzyme from the rejecting allografts at day 5 was also increased significantly to levels that were 280±47% of syngeneic controls. Cyclic GMP levels were also measured in ventricular myocytes isolated from both sets of grafts at day 5 after transplantation (Fig. 7) . Cyclic GMP levels were increased significantly in cardiac myocytes (Fig. 8, left panel) . There was also increased staining indicative of iNOS in a diffuse cytoplasmic pattern associated with the periphery of the cardiac muscle fibers of the rejecting allografts (Fig. 8 a) . These changes were not observed in sections from the syngeneic grafts (Fig. 8 c) . Isolated and purified myocytes from both sets of grafts were also immunostained with the anti-iNOS antiserum. The purified myocytes from the rejecting cardiac allografts revealed a diffuse peripheral pattern of increased iNOS staining (Fig. 9 b) in comparison with purified myocytes from the syngeneic grafts (Fig. 9 c) . The mononuclear cell fraction from the rejecting allografts also showed increased iNOS staining (Fig. 9 a) . In addition, the neonatal cultured myocytes in which NOS had been induced by treatment with cytokines showed positive iNOS staining whereas unstimu- lated neonatal myocytes were negative (Fig. 10, a and b) . Neither tissue sections nor purified myocytes or inflammatory cells showed positive immunostaining with control nonimmune serum (data not shown).
Discussion
The data from this study demonstrate for the first time that the inducible NO synthase mRNA, protein, and enzyme activity are expressed in the myocardium during cardiac allograft rejection. Significant levels of iNOS were not present in syngeneic control hearts. The iNOS mRNA and protein were also present in isolated purified myocyte preparations from the rejecting allografts. Immunocytochemistry indicated that iNOS protein was ........ b increased in macrophages infiltrating the myocardium and in cardiac muscle fibers and in isolated purified cardiac myocytes from the rejecting allografts. The increased iNOS activity in the rejecting cardiac allografts was associated with significant increases in myocardial cyclic GMP content and with depressed ventricular contractility as indicated by palpation of weakened cardiac contractions in vivo. The increased iNOS activity in the rejecting cardiac allografts was also associated with histological evidence of myocardial edema and patchy necrosis of cardiac muscle fibers.
The iNOS mRNA in the myocardial tissue and isolated cardiac myocytes from the rejecting hearts was measured using a cDNA cloned from RAW 260.1 macrophages by Xie et al. (25) and the enzyme protein was assessed in Western blots c d Figure 9 . The isolated and purified myocytes from a rejecting allograft (b) revealed a diffuse punctate pattern of increased iNOS immunostaining which appears more intense along the plasma membrane in comparison to myocytes from a syngeneic control graft (c). Mononuclear cell-rich fraction from rejecting allograft (a) also showed increased iNOS staining of both macrophages and myocytes. Hematoxylin and eosin stained myocytes (d) from the same sample as shown in (b). x300.
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Yang et al. At day five after heart transplantation the cellular infiltrate in the rejecting myocytes was primarily macrophages and lymphocytes along with a few polymorphonuclear leukocytes. Increased immunostaining for iNOS was apparent in the infiltrating macrophages and also in some of the lymphocytes in the tissue sections. Mononuclear staining for iNOS was also very apparent in the fraction from the density gradient that contained macrophages attached to damaged cardiac myocytes. Endothelial cells lining small vessels in the rejecting allografts also revealed increased immune staining for iNOS.
In different cell systems NO functions as both a paracrine as well as an autocrine messenger to transduce intracellular biochemical events. NO produced by iNOS in the infiltrating macrophages may affect adjacent cardiac myocytes in a fashion analogous to the effects of NO synthesized by endothelial and endocardial cells to depress the contractile function of adjacent heart muscle cells (11, 13, 27) . Hoffman, Langrehr and colleagues have also reported evidence that NO synthesis by lymphocyte subsets may modulate alloantigen-induced activation of cytotoxic lymphocytes in vivo during the allograft response (28) (29) (30) .
Immunostaining of cardiac myocytes with the rabbit antiserum to iNOS was more intense in cardiac muscle fibers and in purified cardiac myocytes from the rejecting hearts than in tissue sections and isolated and purified cardiac myocytes from the syngeneic grafts. These findings, plus the significant amount of iNOS protein apparent on the Western blots from ventricular tissue and from the isolated and purified cardiac myocytes from the rejecting allografts, provide additional evidence that iNOS was induced not only in inflammatory cells but also in the cardiac myocytes during transplant rejection. Whether NO produced by iNOS in cardiac muscle cells during transplant rejection influences cardiac performance is unknown at this time. Autocrine effects of NO produced in heart muscle to reduce myocardial contractility have been reported, however (12, 16, 31) .
The enzyme activity of iNOS in the rejecting hearts was several fold higher than the low level of activity found in syngeneic control grafts. The enzyme activity of iNOS is directly influenced by the availability of the substrate L-arginine, is continuous for long periods of time and produces much higher levels of nitric oxide than those produced by the constitutive isoforms (5) (6) (7) . The activity of the constitutive NO synthases is dependent upon calcium and calmodulin, whereas that of iNOS does not require calcium and calmodulin which were omitted from the incubation mixture used to assess enzyme activity (5, 7, 25, 32) . The finding that iNOS enzyme activity is increased in rejecting cardiac allografts is consistent with related data obtained in transplant models by others. Langrehr and colleagues (29, 30) reported that the blood levels of nitrite, the stable breakdown product of NO, were increased in rats during renal, liver and cardiac allograft rejection (30) and that nitrite levels also rose significantly in a sponge allograft model of rejection (29) . In endomyocardial biopsy specimens from patients with dilated cardiomyopathy iNOS enzyme activity was also reported to be higher than in biopsies that were histologically normal from other patients (33) .
Nitric oxide acts upon its target molecule soluble guanylyl cyclase to stimulate the formation of cyclic GMP (5-7). Cyclic GMP levels in isolated cardiac myocytes from rejecting cardiac allografts with increased iNOS mRNA, protein and enzyme activity were elevated markedly above levels found in myocytes from the syngeneic grafts. This result is similar to that of Schultz et al who observed increased cyclic GMP in myocardium from guinea pig hearts in which iNOS had been induced with IFNy and endotoxin (13) . In studies by Brady et al. (31) the amplitude of contraction of isolated cardiac myocytes was reduced in cells from animals treated with endotoxin to induce iNOS (31) and also was reduced in a dose dependent fashion in myocytes from normal guinea pigs that were incubated in media containing NO or the NO donor sodium nitroprusside (9) . The latter effect was duplicated by incubating the cardiac myocytes in media containing increasing concentrations of the cyclic GMP analogue, 8-bromo-cyclic GMP (9) . It Ongoing investigations in our laboratory will attempt to define the role of iNOS induction in both of these consequences by demonstrating the effect of inhibitors of iNOS enzyme activity and of iNOS induction upon the hemodynamic and pathological sequelae of allograft rejection in this model.
Conceivably, high levels of NO produced by iNOS induced in cardiac myocytes and in infiltrating macrophages during allograft rejection could modify ventricular contractility and the responses of heart muscle to muscarinic and adrenergic stimuli. Administration of inhibitors of NOS to isolated perfused normal hearts (5, 12, 16) or to isolated myocytes from normal adult rat hearts was not associated with significant changes in contractile force or amplitude. However, Finkel et al. (38) observed that administration of cytokines acutely depressed tension development in rat papillary muscles, an effect which was reversed by administration of drugs which inhibit NOS. In studies by Balligand and co-workers, inhibitors of NO synthesis or activity impeded muscarinic retardation of the beating rate of neonatal myocytes and augmented the inotropic responses of both neonatal and adult rat cardiac myocytes to beta adrenergic agonists (12, 16) . The induction of iNOS by endotoxin in guinea pig hearts by Brady et al. (31) was associated with reduced amplitude of basal contraction which was partially reversed by inhibition of NOS.
The causes of the necrosis of cardiac myocytes that is characteristic of cardiac allograft rejection are incompletely understood and have been attributed primarily to actions of cytotoxic lymphocytes (4, 17) . NO synthesized by iNOS in macrophages and cardiac myocytes may also exert cytotoxic effects on the heart muscle cells during allograft rejection. Evidence has been accumulated that NO synthesized by iNOS in activated macrophages is cytostatic and cytotoxic to bacteria and parasites and to tumor and pancreatic islet cells (36, (39) (40) (41) (42) . Induction of iNOS in endothelial cells by cytokines was associated with increased cell death of the endothelial cells, an effect which was blocked by inhibitors of NO synthesis (43) . It is believed that the cytotoxicity of NO is mediated in part by the binding of NO to iron-containing enzymes such as enzymes in the mitochondrial electron transfer chain (complexes I, IV, V), aconitase and ribonucleotide reductase (5, 7, 35, (39) (40) (41) (42) . The inducible NO synthase has also been implicated in autoimmune complex injury and in other inflammatory reactions that produce tissue damage and edema (44, 45) . In these situations, oxygen radicals may combine with NO to form perioxynitrite leading to production damaging of hydroxyl radicals (46, 47) . Consistent with the idea that NO produced by inducible NO synthase may be involved in the destruction of heart tissue during cardiac allograft rejection are the observations by Lancaster 
